Anne G. Semb

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

2026 ESC Guidelines on cardiac rehabilitation.

2026 ESC Guidelines on cardiac rehabilitation.

Journal: European journal of preventive cardiology

Published: August 28, 2026

2026 ESC Guidelines on cardiac rehabilitation.

2026 ESC Guidelines on cardiac rehabilitation.

Journal: European heart journal

Published: August 28, 2026

Why Cardio-Rheumatology?

Why Cardio-Rheumatology?

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: June 19, 2026

2025 ESC Guidelines for the management of myocarditis and pericarditis

2025 ESC Guidelines for the management of myocarditis and pericarditis

Journal: Giornale italiano di cardiologia (2006)

Published: December 24, 2025

Cardiovascular pharmacotherapy in 2025.

Cardiovascular pharmacotherapy in 2025.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: December 18, 2025

Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis.

Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritis.

Journal: RMD open

Published: October 07, 2025

From consensus to action: Implementing cardiovascular prevention guidelines in primary healthcare.

From consensus to action: Implementing cardiovascular prevention guidelines in primary healthcare.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: October 03, 2025

Reply to Dziewierz and to Zhang and Yang.

Reply to Dziewierz and to Zhang and Yang.

Journal: Seminars in arthritis and rheumatism

Published: October 02, 2025

2025 ESC Guidelines for the management of myocarditis and pericarditis.

2025 ESC Guidelines for the management of myocarditis and pericarditis.

Journal: European heart journal

Published: August 29, 2025

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action.

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action.

Journal: European journal of heart failure

Published: June 14, 2025

Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries.

Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries.

Journal: The Lancet. Rheumatology

Published: June 01, 2025

Similar myocardial infarction characteristics and short-term outcomes in patients with and without inflammatory joint diseases: A nationwide Norwegian study.

Similar myocardial infarction characteristics and short-term outcomes in patients with and without inflammatory joint diseases: A nationwide Norwegian study.

Journal: Seminars in arthritis and rheumatism

Published: March 09, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026